Ketogenic Diet and Lipids
Historically a ketogenic diet was used as early as the 1920s to treat epilepsy in children. More recently it has become popular as a way to lose weight and has been promoted for the management of Type II Diabetes.
What is a Ketogenic Diet?
This diet severely restricts carbohydrates, typically providing only 5-10% of calories (about 20-50g/ day - the amount you’d find in 2-3 slices of bread), compared to the 50% currently recommended. It also includes moderate levels of protein (approximately 10% of calories) with no restriction of fat (70-80% of calories).
The idea behind the ketogenic diet is to use fat as a fuel source rather than carbohydrates, which is the body’s preferred source of fuel. This process produces ketones. Ketosis occurs when these ketone bodies accumulate in the blood. Exact quantities of carbohydrates to induce ketosis will vary, as achieving ketosis is highly individualised.
Many types of ketogenic diets exist, but all ban carb-rich foods such as sweet sugary foods, breads, cereals, pasta, rice, potatoes and other starchy vegetables and fruit juices. But also foods like beans and legumes, and most fruits. Most ketogenic diets allow foods high in saturated fat and cholesterol, such as fatty cuts of meat, processed meats, lard, butter, cream, and cheese, as well as sources of unsaturated fats, including nuts, seeds, avocados, plant oils, and oily fish.
As a result, a ketogenic diet can end up being high in saturated fat and cholesterol, and low in foods which we know are cardio-protective e.g. legumes, whole grains, fibre-rich starchy vegetables and most fruits.
The Effect of a Ketogenic Diet on Weight and Cardiometabolic Risk Factors.
Because of the increasing popularity of the ketogenic diet, the US National Lipid Association Nutrition and Lifestyle Task Force recently reviewed the evidence and published a scientific statementi on the effect of these types of diets on body weight and cardiometabolic risk factors, including lipids. They concluded:-
- Very low carbohydrate diets are not superior to other dietary approaches for weight loss and are difficult to maintain in the long term.
- They may have some advantages related to appetite control, triglyceride reduction and reduction in the use of medication in Type II Diabetes management. BUT only in the short term, as longer-term studies have not been conducted.
- Studies have shown mixed effects on LDL-C levels, with some studies showing an increase. This appears to be related to the saturated fat content of the diet.
- Some individuals experience extreme effects of a ketogenic diet on LDL-C and this may be related to genetic factors. For this reason the National Lipid Association expressed concern for ketogenic diets being used by people with hypercholesterolaemia, particularly Familial Hypercholesterolaemia. They concluded that this diet is contraindicated for these conditions.
- The Ketogenic Diet is also contraindicated in patients with severe hypertriglyceridaemia due to genetic or acquired causes of lipoprotein lipase dysfunction
- There’s no clear evidence for advantages on other cardiometabolic risk markers
- There’s minimal data regarding the long-term safety and efficacy (> 2 years).
- According to findings from observational studies, very low carbohydrate diets are associated with an increased risk of cardiovascular mortality.
It’s also worth noting this diet has been associated with short term side effects such as gastrointestinal complaints including constipation, nausea, and abdominal pain which are often experienced in the first few weeks. Some individuals may experience symptoms described as the ‘keto flu’ within 2 to 4 days of starting a keto diet, which may occur as the body adapts to using ketone bodies for fuel. It may last a few days to one week and include light-headedness, dizziness, fatigue, difficulty exercising, poor sleep and constipation.
The effect of the ketogenic diet on long term cardiovascular risk remains unknown. It challenges the current nutrition recommendations from various organisations such as Public Health England (PHE)ii, The National Institute for Health and Care Excellence (NICE)iii,iv and the recent European Society of Cardiology/ European Atherosclerosis Society guidelines for the management of dyslipidaemiasv as it severely restricts or eliminates foods associated with cardio-protective benefits, and encourages a high intake of foods known to increase risk, such as foods high in saturated fat.
The most important way to prevent CVD is to promote a healthy lifestyle throughout the life span. Cardio-protective dietary patterns emphasise eating vegetables, fruits, nuts, whole grains, vegetable proteins, lean animal protein and fish and minimise the intake of saturated fats, processed meats, refined carbohydrate foods and foods with added sugars and sweetened drinks.
[i] Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force
Kirkpatrick, Carol F. et al. Journal of Clinical Lipidology, Volume 0, Issue 0. https://www.lipidjournal.com/article/S1933-2874(19)30267-3/fulltext
[ii] The Eatwell Guide: https://www.gov.uk/government/publications/the-eatwell-guide
[iii] NICE Guideline: Familial hypercholesterolaemia: identification and management. Clinical Guideline (CG71)
[iv] NICE Guideline: Cardiovascular disease: risk assessment and reduction, including lipid modification. Clinical guideline [CG181]
[v] François Mach, Colin Baigent, Alberico L Catapano, et al ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart Journal, , ehz455, https://doi.org/10.1093/eurheartj/ehz455
- Low Carbohydrate diets, Weight management, Type 2 diabetes and Dyslipidaemia
- Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia
- Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
- Diagnosis, management and prognosis of familial hypercholesterolaemia in a UK tertiary cardiac centre
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- Does diet quality or nutrient quantity contribute more to health?
- Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options
- Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care
- Identifying FH Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors
- Higher circulating and tissue levels of Linoleic Acid associated with lower risk of major cardiovascular events
- Substituting red meat with high-quality plant protein sources results in favourable changes in blood lipids and lipoproteins
- Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat—a randomized controlled dietary intervention study
- The Timing of Cardiovascular Health Decline and Its Association With Subclinical Atherosclerosis in Adulthood
- Is diet management helpful in familial hypercholesterolemia? Lynne Garton our Dietetic Adviser, explores.
- Statins may have a role in treating serious mental illness
- Increased intensity plus adherence maximises statin benefits
- Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study
- Higher intakes of fibre and wholegrains associated with lower rates of non-communicable diseases, including Cardiovascular Disease and Coronary Heart Disease.
- Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia May Not Be Higher
- CVD Prevention Return on Investment Tool
- Cholesterol Management Clinical Practice Guidelines in US
- REDUCE-IT: 25% Reduction in MACE With High-Dose EPA
- Raised Lp(a) Slashed in CV Patients on Novel Antisense Agent
- Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
- Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk
- Walnut Consumption Controlled Trial
- Erectile Dysfunction Linked to Future CVD Events
- Ezetimibe - Likely to Be Beneficial For All
- Adverse effects of statin therapy: perception vs. the evidence
- Levels of lipoprotein(a) [Lp(a)] need to be reduced by substantially more than has been achieved in recent trials
- Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population
- How much does plasma lipoprotein(a) need to be lowered to produce a clinically meaningful reduction in the risk of coronary heart disease?
- The effects of Vitamin D supplementation on statin adherence
- Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis
- Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels
- Diabetes UK Launches new evidence based guidelines for the prevention and management of diabetes
- Effects of walnut consumption on blood lipids and other cardiovascular risk factors: an updated meta-analysis and systematic review of controlled trials
- Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- The complex molecular genetics of familial hypercholesterolaemia
- Parents’ views of genetic testing and treatment of familial hypercholesterolemia in children: a qualitative study
- Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
- Marriage Tied to Lower Risk of Fatal Heart Attacks and Strokes
- How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol.
- Special Issue Section: Improving the Global Care of Familial Hypercholesterolaemia
- Familial hypercholesterolaemia patient support groups and advocacy: A multinational perspective
- Special Issue Section: Improving the Global Care of Familial Hypercholesterolaemia
- SHARP Annual Scientific Meeting 2018: Save the Date
- Issues & Answers in Cardiovascular Disease, 16-17 November 2018, EMCC Nottingham UK
- HEART UK responds to debate on the true benefits and risks of statins
- HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom
- HEART UK study finds high street restaurants serve meals with four times recommended saturated fat
- HEART UK responds to study that says good cholesterol may not always protect you from heart disease